Chile - Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry
Since 2012, Chile Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry grew 15.9% year on year. In 2015, the country was ranked number 29 among other countries in Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry at $28,786,954.1 Million PPP. Chile is overtaken by Norway, which was number 28 with $36,963,598.93 Million PPP and is followed by Romania at $26,524,562.71 Million PPP. United States topped the ranking with $70,565,318,932.39 Million PPP in 2019, an increase of 3.3% versus 2018. China, Japan and Germany respectively ranked number 2, 3 and 4 in this ranking. Iceland witnessed the best average annual growth at +43.9% per year, while Lithuania witnessed the worst performance at -42.6% per year.
Loading...
| Date | Million US Dollars PPP |
|---|---|
| 2015 | 28,786,954.10 |
| 2014 | 28,034,725.25 |
| 2013 | 33,671,136.29 |
| 2012 | 18,476,204.78 |
How does Chile rank in Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry?
| # | 69 Countries | Million US Dollars PPP | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
United States
|
70,565,318,932.39 | 2019 | +3.3 % | +4.5 % | View data | |
| 2 |
#2
China
|
13,956,388,273.35 | 2019 | +4.5 % | +6.1 % | View data | |
| 28 |
#28
Norway
|
36,963,598.93 | 2019 | -2.1 % | +0.1 % | View data | |
| 29 |
#29
Chile
|
28,786,954.10 | 2015 | +2.7 % | +15.9 % | View data | |
| 30 |
#30
Romania
|
26,524,562.71 | 2019 | +1.3 % | -7.3 % | View data | |